Email

sgh@bcm.edu

Positions

Professor

Smith Breast Center - Hilsenbeck
Baylor College of Medicine
Houston, TX US

Director, Quantitative Sciences Share Resource

Dan L Duncan Comprehensive Cancer Center
Baylor College of Medicine
Houston, Texas United States

Faculty Senator

Baylor College of Medicine
Houston, Texas United States

Addresses

BCM-Cullen Building (Office)

Room: BCMC-333A
Houston, TX 77030
United States

Education

Ph.D. from University Of Miami

01/1990 - Miami, FL United States

Certifications

Fellow

American Statistical Association

PStat

American Statistical Association

Certified Professional Statistician

Professional Interests

• Design and statistical analysis of translational experiments and clinical trials

Professional Statement

Dr. Hilsenbeck has a PhD in applied biostatistics, and has long-standing interests in biostatistical and informatics collaboration, especially in cancer research. She is the statistician of record on a number of investigator-initiated multi-center clinical trials and leads several of the biostatistics and informatics focused resources at Baylor, including: Biostatistics and Informatics Shared Resource, Duncan Cancer Center; and Biostatistics, Duncan Institute for Translational Research.
Dr. Hilsenbeck's personal research interests focus on design and analysis of prognostic and predictive biomarker studies. She is also committed to teaching. She serves on mentoring committees, leads the biostatistics course for TBMM graduate students (elective to satisfy biostatistics training requirement for other programs), and is regularly invited to teach in national and international workshops.

Websites

Selected Publications

• Yuan Y, Hess KR, Hilsenbeck SG, Gilbert MR "Bayesian Optimal Interval Design: A Simple and Well-Performing Design for Phase I Oncology Trials.." 2016;22:4291-4301. Pubmed PMID: 27407096
• Hertz DL, Kidwell KM, Hilsenbeck SG, Oesterreich S, Osborne CK, Philips S, Chenault C, Hartmaier RJ, Skaar TC, Sikora MJ, Rae JM. "CYP2D6 genotype is not associated with survival in breast cancer patients treated with tamoxifen: results from a population-based study.." Breast Cancer Res Treat.. 2017; Pubmed PMID: 28730340
• Mo Q, Shen R, Guo C, Vannucci M, Chan KS, Hilsenbeck SG. "A fully Bayesian latent variable model for integrative clustering analysis of multi-type omics data.." Biostatistics. 2017; Pubmed PMID: 28541380
• Musher BL, Rowinsky EK, Smaglo BG, Abidi W, Othman M, Patel K, Jawaid S, Jing J, Brisco A, Leen AM, Wu M, Sandin LC, Wenthe J, Eriksson E, Ullenhag GJ, Grilley B, Leja-Jarblad J, Hilsenbeck SG, Brenner MK, Loskog ASI. "LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 study.." Lancet Oncol. 2024;25(4):488-500. Pubmed PMID: 38547893

Memberships

American Statistical Association

Member

Baylor College of Medicine Faculty Senate

Senator, Duncan Cancer Center (11/2015 - 10/2022)